Post by juthi52943 on Dec 28, 2023 11:08:16 GMT
Ad now let's go! Deeper, more accurate insights with real-time behavioral data Real-time behavioral data is useful for reaching healthcare professionals in several use cases, including marketing a new device or therapy, as well as influencing the prescriptions they write. Real-time behavioral data is particularly important for pharmaceutical companies and medical device manufacturers because it allows them to.
Better understand existing and potential customers. , including Job Function Email List the top funnel Improve campaign results Apply third-party market data to gain richer insights. Pharmaceutical marketing As noted in Part New therapies and drugs don't arrive on shelves overnight. It can take ten years or more - and sometimes tens of millions of dollars - to conduct the necessary research.
A clinical trials and finally FDA approval before they can be released. Then there is a relatively short window of opportunity (ten years maximum) to make a splash and recoup the expenses. So, in addition to targeting consumers, the pharmaceutical industry also needs the support of healthcare professionals. Let's take the same example from Part , the new therapy for dry eyes. In this scenario, the company will want to get the attention of ophthalmologists.
Better understand existing and potential customers. , including Job Function Email List the top funnel Improve campaign results Apply third-party market data to gain richer insights. Pharmaceutical marketing As noted in Part New therapies and drugs don't arrive on shelves overnight. It can take ten years or more - and sometimes tens of millions of dollars - to conduct the necessary research.
A clinical trials and finally FDA approval before they can be released. Then there is a relatively short window of opportunity (ten years maximum) to make a splash and recoup the expenses. So, in addition to targeting consumers, the pharmaceutical industry also needs the support of healthcare professionals. Let's take the same example from Part , the new therapy for dry eyes. In this scenario, the company will want to get the attention of ophthalmologists.